Article
A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma.
Advances in experimental medicine and biology - 1 Jan 2015
Shrotriya Sangeeta, Agarwal Rajesh, Sclafani Robert A
Abstract excerpt
Head and neck squamous cell carcinoma (HNSCC) accounts for around 6% of all cancers in the USA. Few of the greatest obstacles in HNSCC include development of secondary primary tumor, resistance and toxicity associated with the conventional treatments, together decreasing the overall 5-year survival rate in HNSCC patients to ≤50%. Radiation and chemotherapy are the conventional treatment options available for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
